Search company, investor...
Biotricity company logo


Founded Year




Date of IPO


Market Cap


About Biotricity

Biotricity (NASDAQ: BTCY) is a modern medical technology company focused on delivering remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement.

Headquarters Location

203 Redwood Shores Pkwy, Suite 600

Redwood City, California, 94065,

United States


Biotricity's Product Videos

Bioheart AM ONEPAGERUNAP6-1 Page 1.jpg

Compete with Biotricity?

Ensure that your company and products are accurately represented on our platform.

Biotricity's Products & Differentiators


    Real-time cardiac monitor and cloud system, one piece solution, built in cellular technology

Expert Collections containing Biotricity

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biotricity is included in 5 Expert Collections, including Medical Devices.


Medical Devices

11,648 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,854 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Health Monitoring & Diagnostics

842 items

Companies offering products that help assess patients’ state of health and well-being from a distance. Tagged as #RemoteMonitoring&Diagnostics


Health IT

8,881 items

Biotricity Patents

Biotricity has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics





Application Date


Grant Date



Related Topics



Latest Biotricity News

Biotricity stock rises on surpassing $10M in annual revenue run rate

Nov 21, 2022

Nov. 21, 2022 8:43 AM ET Biotricity, Inc. (BTCY) By: Ravikash , SA News Editor atiatiati Biotricity (NASDAQ: BTCY ) said it surpassed $10M in annual revenue run rate. The company added that it delivered revenue growth in 9 out of the last 10 consecutive quarters. Last week, Biotricity reported its FQ2 results , which had missed analysts estimates, despite revenue rising about 32% Y/Y. "I am committed to continuing to drive growth and realize our potential. Our focus remains on providing the cardiac health market with disruptive, superior digital and AI technology at competitive pricing with unrivaled support to our customers and physician partnerships," said Biotricity Founder and CEO Waqaas Al-Siddiq. On Nov. 18, Biotricity said that its strategy is to strengthen cash flow, reduce capital expenditures, capture market share, and drive top-line growth. The company noted that it was cross- and up-selling its full suite of cardiac monitoring products. BTCY +7.55% to $1.14 premarket Recommended For You

Biotricity Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Biotricity Rank

Biotricity Frequently Asked Questions (FAQ)

  • When was Biotricity founded?

    Biotricity was founded in 2014.

  • Where is Biotricity's headquarters?

    Biotricity's headquarters is located at 203 Redwood Shores Pkwy, Suite 600, Redwood City.

  • What is Biotricity's latest funding round?

    Biotricity's latest funding round is IPO.

  • Who are the investors of Biotricity?

    Investors of Biotricity include MetaSolutions.

  • Who are Biotricity's competitors?

    Competitors of Biotricity include Healionics, Lumenis, BioTelemetry, Cutera, nContact Surgical and 13 more.

  • What products does Biotricity offer?

    Biotricity's products include Bioflux and 1 more.

Compare Biotricity to Competitors


C2C is a medical device company developing a portfolio of medical devices.

Tursiop Technologies

Tursiop Technologies Llc is a medical device company. It had developed the Tt1 General Purpose Coil for use in imaging machines.

Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

Gaymar Industries

Gaymar Industries is a manufacturer of specialty medical devices

SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.